Profile
AVR ABT BSX-PA BSX SYK MDT
Company Name Anteris Technologies Global Corp. Abbott Laboratories Boston Scientific Corporation Boston Scientific Corporation Stryker Corporation Medtronic plc
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices
Market Cap $141.72M $239.05B $175.45B $154.29B $143.53B $110.15B
Employees 0.14K 114.00K 45.00K 53.00K 53.00K 95.00K
CEO Mr. Wayne Geoffrey Paterson Robert B. Ford Mr. Michael F. Mahoney Michael F. Mahoney Mr. Kevin A. Lobo Geoffrey Straub Martha
Ratings
AVR ABT BSX-PA BSX SYK MDT
Quant Rating Score 2 4 3 3 3
Quant Rating Sell Buy Neutral Neutral Neutral
Trading
AVR ABT BSX-PA BSX SYK MDT
Last Close $3.96 $137.4 $122.18 $104.29 $392.23 $85.97
High 52 $8.78 $140.22 $122.18 $106.66 $399.9 $94.5
Low 52 $2.47 $100.07 $122.18 $72.96 $315.94 $76.84
Price vs. 52 Week High -54.9 % -2.01 % 0 % -2.22 % -1.92 % -9.03 %
Price vs. 52 Week Low 60.32 % 37.3 % 0 % 42.94 % 24.15 % 11.88 %
Total Return
AVR ABT BSX-PA BSX SYK MDT
1 Month Return 8.79 % 4.65 % 0 % -0.2 % 4.14 % 6.56 %
3 Month Return -14.84 % 8.52 % 0 % 1.91 % 6.65 % -2.56 %
6 Month Return -27.87 % 19.2 % 0 % 14.04 % 6.17 % 5.36 %
9 Month Return 0 % 21.88 % 0 % 25.53 % 8.55 % -3.89 %
YTD Return -29.03 % 21.47 % 0 % 16.76 % 8.94 % 7.62 %
1 Year Return 0 % 31.01 % 0 % 35.27 % 15.19 % 7.4 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
AVR ABT BSX-PA BSX SYK MDT
Dividend Yield Percentage (TTM) - 1.66 % - - 0.87 % 3.26 %
Dividend Paid and Capex Coverage Ration (TTM) -43 % 1.57 % 3.96 % 3.96 % 2.2 % 1.29 %
Dividend Per Share (TTM) - 2.28 % - - 3.28 % 2.8 %
Payout Ratio (TTM) - 28.92 % 1.13 % 1.13 % 43.2 % 76.97 %
Profitability
AVR ABT BSX-PA BSX SYK MDT
Gross Profit Margin TTM 53.05 % 55.89 % 67.15 % 67.15 % 63.57 % 64.06 %
Return on Assets TTM -139.26 % 16.58 % 5.06 % 5.06 % 6.21 % 5.09 %
Return on Equity TTM -292.3 % 30.76 % 9.56 % 9.56 % 10.73 % 9.62 %
Return on Capital Employed TTM -139.14 % 10.5 % 8.77 % 8.77 % 9.61 % 7.56 %
Net Income Per EBT TTM 100.15 % 183.58 % 81.97 % 81.97 % 85.78 % 82.85 %
EBT Per Ebit TTM 132.42 % 102.35 % 80.59 % 80.59 % 91.04 % 94.51 %
EBIT Per Revenue TTM -2476.5 % 16.97 % 17.52 % 17.52 % 15.77 % 17.76 %
Cash Flow To Debt Ratio TTM -3326.62 % 67.59 % 32.56 % 32.56 % 29.81 % 24.7 %
Receivables Turnover TTM 13.19 4.38 6.52 6.52 5.86 5.15
Payables Turnover TTM 0.21 4.43 5.74 5.74 - 4.74
Inventory Turnover TTM 3.22 2.81 2.01 2.01 1.66 2.12
Fixed Asset Turnover TTM 43.98 % 387.34 % 517.94 % 517.94 % 656.62 % 490.52 %
Asset Turnover TTM 4.24 % 51.99 % 43.73 % 43.73 % 50.47 % 36.58 %
Operating Cash Flow Per Share TTM -2.85 5.12 2.58 2.58 11.23 5.49
Free Cash Flow Per Share TTM -2.92 3.81 1.94 1.94 9.37 4.04
Cash Per Share TTM 207.64 % 391.71 % 49.08 % 49.08 % 631.12 % 699.13 %
Operating Cash Flow Sales Ratio TTM -2695.85 % 21.14 % 21.72 % 21.72 % 18.47 % 21 %
Free Cash Flow Operating Cash Flow Ratio TTM 102.33 % 74.38 % 75.37 % 75.37 % 83.42 % 73.61 %
Cash Flow Coverage Ratios TTM -3326.62 % 67.59 % 32.56 % 32.56 % 29.81 % 24.7 %
Price To Free Cash Flows Ratio TTM -1.34 35.91 53.62 53.7 40.12 21.24
Price To Operating Cash Flows Ratio TTM -0.87 26.82 40.35 40.41 33.43 15.65
Price Cash Flow Ratio TTM -0.87 26.82 40.35 40.41 33.43 15.65
Income Statement (TTM)
AVR ABT BSX-PA BSX SYK MDT
Revenue $0B $41.95B $16.75B $16.75B $22.6B $33.54B
Gross Profit $0B $23.24B $11.49B $11.49B $14.44B $21.97B
Gross Profit Ratio 46.84% 55.41% 68.61% 68.61% 63.91% 65.51%
EBITDA $-0.08B $10.83B $3.94B $3.94B $5.72B $5.96B
Net Income $-0.08B $13.4B $1.85B $1.85B $2.99B $4.66B
EPS Diluted -3.77 7.64 1.25 1.25 7.76 3.61
Balance Sheet (MRQ)
AVR ABT BSX-PA BSX SYK MDT
Long Term Debt $0B $13.52B $8.84B $8.84B $12.19B $25.64B
Total Liabilities $0.02B $33.51B $17.39B $17.39B $22.34B $43.42B
Total Equity $0.06B $47.9B $22B $22B $20.63B $48.26B
Total Investments $0B $1.24B $0.56B $0.56B $0.84B $6.75B
Total Debt $0B $15.02B $11.15B $11.15B $13.6B $28.52B
Total Assets $0.08B $81.41B $39.4B $39.4B $42.97B $91.68B
Cash Flow Statement (TTM)
AVR ABT BSX-PA BSX SYK MDT
Net Income $-0.08B $13.4B $1.85B $1.85B $2.99B $4.69B
Inventory $-0B $-0.06B $-0.23B $-0.23B $0.05B $-0.29B
Dividends Paid $0B $-3.84B $0B $0B $-1.22B $-3.59B
Operating Cash Flow $-0.06B $8.56B $3.44B $3.44B $4.24B $7.04B
Capital Expenditure $-0B $-2.21B $-0.79B $-0.79B $-0.76B $-1.86B
Related Stocks
Ticker Name Price
ABMD Abiomed, Inc. 381.02
ABT Abbott Laboratories 133.69
ADGM Adagio Medical Holdings, Inc. 1.24
AEMD Aethlon Medical, Inc. 1.86
AFIB Acutus Medical, Inc. 0.0018
AHCO AdaptHealth Corp. 9.415
AHPI Allied Healthcare Products, Inc. 0.004
ALGN Align Technology, Inc. 187.83
ALUR Allurion Technologies Inc. 2.49
AMIX Autonomix Medical, Inc. Common Stock 1.24
ANIK Anika Therapeutics, Inc. 10.84
AORT Artivion, Inc. 30.58
APEN Apollo Endosurgery, Inc. 10
APYX Apyx Medical Corporation 2.215
ASXC Asensus Surgical, Inc. 0.3479
ATEC Alphatec Holdings, Inc. 10.89
AVNS Avanos Medical, Inc. 12.15
AXDX Accelerate Diagnostics, Inc. 0.034
AXGN AxoGen, Inc. 10.485
AXNX Axonics, Inc. 70.98
ETFs With Exposure to AVR
Ticker ETF Name Weight Percentage Price
IWN iShares Russell 2000 Value ETF 0.00294 157.63
IWO iShares Russell 2000 Growth ETF 0.00173 284.86
HDG ProShares Hedge Replication ETF 0.000332616 49.33
UWM ProShares Ultra Russell2000 0.00190772 37.59
IWC iShares Micro-Cap ETF 0.01502 127.655
URTY ProShares UltraPro Russell2000 0.00152651 39.23
VTWV Vanguard Russell 2000 Value Index Fund 0 138.785
VTWG Vanguard Russell 2000 Growth Index Fund 0 208.045
VTWO Vanguard Russell 2000 Index Fund 0 87.09
RSSL Global X Funds 0 84.895
Unlock